💊 Medicine AT September 7, 2026

Lamotrigin Sandoz GmbH 25 mg - lösliche Tabletten 25 mg (Tablette zur Herstellung einer Suspension zum Einnehmen)

📷 Wikipedia: Lamotrigine · Source

ATC: N03AX09
Reason: Verknappung des Wirkstoffes
Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich
Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-07]

⚠️

Shortage ongoing

LAMOTRIGIN is currently in short supply in AT.

📈 Timeline

3 days active so far

September 8, 2026 September 10, 2026

A plain-language summary will appear here shortly. Read the official notice below.

🔬 Medical / technical details (for professionals)

Active substance(s)

LAMOTRIGIN

Agency-published detail

🚫 Parallel export ban active · ATC: N03AX09 · Reason: Verknappung des Wirkstoffes · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-07]

First published

September 7, 2026

Last refreshed by us

14 hours ago

Severity (as classified)

High

Official source

https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

🔔 Stay informed

Get an email if there's an update.

Free · One click to unsubscribe

📤 Tell someone

🦋 Bluesky 𝕏 🐘 💬 WhatsApp ✈️ Telegram ✉️ Email

📋 Quick facts

Status

Shortage ongoing

Affects

First detected by us

September 8, 2026

Agency-reported start

September 7, 2026

Days active

Related alerts

High AT 1 week ago

Lamotrigin 1A Pharma 50 mg - lösliche Tabletten (Tablette zur Herstellung einer Suspension zum Einnehmen)

Lamotrigine 1A Pharma 50 mg - soluble tablets (tablets for oral suspension) Shortage of active ingredient. Affected packs: 30-tablet box, blister pack [unavailable since September 2026].

High AT 2 months ago

Lamotrigin 1A Pharma 25 mg - lösliche Tabletten (Tablette zur Herstellung einer Suspension zum Einnehmen)

Lamotrigine 1A Pharma 25 mg soluble tablets (tablets for oral suspension) are unavailable due to a shortage of the active ingredient.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?

Lamotrigin Sandoz GmbH 25 mg - lösliche Tabletten 25 mg (Tablette zur Herstellung einer Suspension zum Einnehmen). 🚫 Parallel export ban active · ATC: N03AX09 · Reason: Verknappung des Wirkstoffes · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-07]

▸ When was this alert issued?

This alert was issued on September 7, 2026 by BASG (Austria).

▸ Which countries are affected?

The alert applies to Austria.

▸ How serious is this alert?

Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.

▸ What should I do?

If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.

▸ Where can I find the official notice?

The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.